Childhood Lymphoma Research

Scientists at the University of Chicago have made several fundamental discoveries about the causes of cancer, including the identification of chromosomal rearrangements that activate cancer-causing genes. This important discovery contributed to the development of current targeted gene therapies.

Recently, James Nachman, MD, developed and led the first national, randomized trial for children and adolescents with Hodgkin lymphoma. The study examined the role of radiation therapy in patients who have a complete response to chemotherapy.

Advancing Research Through Partnerships

Our physicians and investigators are members of the University of Chicago Cancer Research Center -- an outstanding and extensive team of laboratory scientists, caregivers, clinical researchers and trainees who work collaboratively to unlock the mysteries behind all types cancer and develop solutions to the complexity of individual cancers.

Our pediatric cancer researchers are also members – and often leaders -- of many national and international cancer research groups including:

• Children's Oncology Group (COG)
• American Society of Pediatric Hematology/Oncology
• American Society of Blood and Marrow Transplantation (ASBMT), the Pediatric Blood and Marrow Transplant Consortium (PBMTC) and the International Blood and Marrow Transplant Registry (IBMTR)
• Pharmacogenetics of Anti-Cancer Agents Research Group (PAAR)

These partnerships and collaborations allow us to bring the latest treatment innovations from the laboratory bench to the patient bedside as quickly as possible.